Wooden pallets scapegoated in J&J Tylenol recall; Inspections follow U.K. drug shortages;

> A trade group says that J&J's McNeil "scapegoated" wooden pallets when it identified them as the culprit of a musty odor that led to a massive recall of Tylenol and other products. Release

> U.K. pharma supply chain members face additional inspections and duties following recent drug shortages. Article

> A Brussels-area NextPharma facility for aseptic and cytotoxic production has been cleared by the FDA. Release

> Particle contamination is cited in the recall of two lots of Ratiopharm's Ratio-Prednisolone eye solution. Release

> API maker Cambrex has acquired Wiesbaden, Germany-based IEP, a maker of enzymes and developer of customized biocatalytic processes. Release

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.